GB9821298D0 - Organic compoundsq - Google Patents

Organic compoundsq

Info

Publication number
GB9821298D0
GB9821298D0 GBGB9821298.8A GB9821298A GB9821298D0 GB 9821298 D0 GB9821298 D0 GB 9821298D0 GB 9821298 A GB9821298 A GB 9821298A GB 9821298 D0 GB9821298 D0 GB 9821298D0
Authority
GB
United Kingdom
Prior art keywords
compoundsq
organic
organic compoundsq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9821298.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Priority to GBGB9821298.8A priority Critical patent/GB9821298D0/en
Publication of GB9821298D0 publication Critical patent/GB9821298D0/en
Priority to AT99950595T priority patent/ATE286725T1/en
Priority to EP99950595A priority patent/EP1121104B1/en
Priority to AU63321/99A priority patent/AU764866B2/en
Priority to PCT/EP1999/007298 priority patent/WO2000019985A2/en
Priority to CN99811633A priority patent/CN1406126A/en
Priority to CA002342340A priority patent/CA2342340C/en
Priority to ES99950595T priority patent/ES2237163T3/en
Priority to TR2001/00931T priority patent/TR200100931T2/en
Priority to BR9914251-1A priority patent/BR9914251A/en
Priority to KR1020017003384A priority patent/KR100603900B1/en
Priority to IDW20010671A priority patent/ID27504A/en
Priority to PT99950595T priority patent/PT1121104E/en
Priority to IL14176299A priority patent/IL141762A0/en
Priority to HU0103883A priority patent/HUP0103883A3/en
Priority to PL348734A priority patent/PL196945B1/en
Priority to SK439-2001A priority patent/SK285250B6/en
Priority to JP2000573347A priority patent/JP4012689B2/en
Priority to CZ20011155A priority patent/CZ302888B6/en
Priority to DE69923200T priority patent/DE69923200T2/en
Priority to NZ510683A priority patent/NZ510683A/en
Priority to IL141762A priority patent/IL141762A/en
Priority to ZA2001/01932A priority patent/ZA200101932B/en
Priority to NO20011471A priority patent/NO331689B1/en
Priority to US09/818,690 priority patent/US20010033866A1/en
Priority to US10/118,183 priority patent/US6565883B2/en
Priority to US10/403,146 priority patent/US20030203025A1/en
Priority to HK03104925.9A priority patent/HK1052473A1/en
Priority to US11/105,967 priority patent/US20050175706A1/en
Priority to US11/592,853 priority patent/US20070053982A1/en
Ceased legal-status Critical Current

Links

GBGB9821298.8A 1998-10-01 1998-10-01 Organic compoundsq Ceased GB9821298D0 (en)

Priority Applications (30)

Application Number Priority Date Filing Date Title
GBGB9821298.8A GB9821298D0 (en) 1998-10-01 1998-10-01 Organic compoundsq
NZ510683A NZ510683A (en) 1998-10-01 1999-10-01 Sustained release oral formulations of rivastigmine
HU0103883A HUP0103883A3 (en) 1998-10-01 1999-10-01 New sustained release oral formulations
SK439-2001A SK285250B6 (en) 1998-10-01 1999-10-01 Oral pharmaceutical composition comprising rivastigmine and use of rivastigmine
EP99950595A EP1121104B1 (en) 1998-10-01 1999-10-01 New controlled release oral formulations for rivastigmine
PCT/EP1999/007298 WO2000019985A2 (en) 1998-10-01 1999-10-01 New sustained release oral formulations
CN99811633A CN1406126A (en) 1998-10-01 1999-10-01 New sustained release oral formulations
CA002342340A CA2342340C (en) 1998-10-01 1999-10-01 New sustained release oral formulations
ES99950595T ES2237163T3 (en) 1998-10-01 1999-10-01 NEW ORAL FORMULATIONS OF REVASTIGMINE CONTROLLED LIBERATION.
TR2001/00931T TR200100931T2 (en) 1998-10-01 1999-10-01 New sustained release oral formulations
BR9914251-1A BR9914251A (en) 1998-10-01 1999-10-01 Oral sustained release formulations
KR1020017003384A KR100603900B1 (en) 1998-10-01 1999-10-01 New sustained release oral formulations
IDW20010671A ID27504A (en) 1998-10-01 1999-10-01 NEW ORAL FORMULATION
PT99950595T PT1121104E (en) 1998-10-01 1999-10-01 NEW ORAL FORMULATIONS OF CONTROLLED LIBERATION
IL14176299A IL141762A0 (en) 1998-10-01 1999-10-01 New oral formulations
AT99950595T ATE286725T1 (en) 1998-10-01 1999-10-01 NEW ORAL MEDICINAL PREPARATIONS FOR RIVASTIGMINE WITH CONTROLLED RELEASE OF ACTIVE INGREDIENTS
PL348734A PL196945B1 (en) 1998-10-01 1999-10-01 New sustained release oral formulations
AU63321/99A AU764866B2 (en) 1998-10-01 1999-10-01 New sustained release oral formulations
JP2000573347A JP4012689B2 (en) 1998-10-01 1999-10-01 New sustained-release oral preparation
CZ20011155A CZ302888B6 (en) 1998-10-01 1999-10-01 Pharmaceutical composition for oral administration comprising rivastigmine and use of rivastigmine
DE69923200T DE69923200T2 (en) 1998-10-01 1999-10-01 NEW ORAL ARRAY PREPARATIONS FOR RIVASTIGGINS WITH CONTROLLED ACTIVE INGREDIENTS
IL141762A IL141762A (en) 1998-10-01 2001-03-01 Controlled release oral formulations for rivastigmine
ZA2001/01932A ZA200101932B (en) 1998-10-01 2001-03-08 New sustained release oral formulations
NO20011471A NO331689B1 (en) 1998-10-01 2001-03-22 ORAL PHARMACEUTICAL COMPOSITION INCLUDING RIVASTIGMIN AND USING RIVASTIGMIN
US09/818,690 US20010033866A1 (en) 1998-10-01 2001-03-27 Sustained release oral formulations
US10/118,183 US6565883B2 (en) 1998-10-01 2002-04-08 Controlled release oral compositions comprising rivastigmine
US10/403,146 US20030203025A1 (en) 1998-10-01 2003-03-31 Sustained release oral formulations
HK03104925.9A HK1052473A1 (en) 1998-10-01 2003-07-09 New sustained release oral formulations
US11/105,967 US20050175706A1 (en) 1998-10-01 2005-04-14 Sustained release oral formulations
US11/592,853 US20070053982A1 (en) 1998-10-01 2006-11-03 Sustained release oral formulations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9821298.8A GB9821298D0 (en) 1998-10-01 1998-10-01 Organic compoundsq

Publications (1)

Publication Number Publication Date
GB9821298D0 true GB9821298D0 (en) 1998-11-25

Family

ID=10839748

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9821298.8A Ceased GB9821298D0 (en) 1998-10-01 1998-10-01 Organic compoundsq

Country Status (1)

Country Link
GB (1) GB9821298D0 (en)

Similar Documents

Publication Publication Date Title
GB9807779D0 (en) Organic compounds
GB9802251D0 (en) Organic compounds
GB9802725D0 (en) Organic compounds
GB9802249D0 (en) Organic compounds
GB9804265D0 (en) Organic compounds
GB9802355D0 (en) Organic compounds
GB9821298D0 (en) Organic compoundsq
GB9803905D0 (en) Organic compounds
GB9804742D0 (en) Organic compounds
GB9801866D0 (en) Organic compounds
GB9801469D0 (en) Organic compounds
GB9802250D0 (en) Organic compounds
GB9801206D0 (en) Organic compounds
GB9802252D0 (en) Organic compounds
GB9802354D0 (en) Organic compounds
GB9800701D0 (en) Organic compounds
GB9802356D0 (en) Organic compounds
GB9802450D0 (en) Organic compounds
GB9800522D0 (en) Organic compounds
GB9802842D0 (en) Organic compounds
GB9803013D0 (en) Organic compounds
GB9803324D0 (en) Organic compounds
GB9803904D0 (en) Organic compounds
GB9800520D0 (en) Organic compounds
GB9803907D0 (en) Organic compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)